Why is the baroreflex a relevant target for both resistant hypertension and heart failure?

29 August 2017 (12:55 - 13:10)
Organised by:
Congress Presentation Part of: Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension CHF - Non pharmacological treatment ESC Premium Access ESC Congress 2017